Chai is building foundation models for drug discovery, specifically to predict interactions between molecules so they could be reprogramed for cures. from TechCrunch https://ift.tt/dXauEMj
Monday, December 15, 2025
OpenAI-backed biotech firm Chai Discovery raises $130M Series B at $1.3B valuation
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment